We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Alpha and Omega Semiconductor
AOSL
$745M
| $3.77M | 0.01% |
422,616
-32,958
| -7% | -$294K |
|
552
Freeport-McMoran
FCX
$110B
| $3.76M | 0.01% |
198,525
-2,925,172
| -94% | -$57.9M |
|
|
ANW
553
DELISTED
Aegean Marine Petroleum Network
ANW
| $3.76M | 0.01% |
261,610
-109,120
| -29% | -$1.54M |
|
554
NovaGold Resources
NG
$3.84B
| $3.74M | 0.01% |
1,262,430
-197,170
| -14% | -$691K |
|
555
Cognizant
CTSH
$28.8B
| $3.71M | 0.01% |
59,393
-4,653
| -7% | -$274K |
|
556
Diana Shipping
DSX
$346M
| $3.7M | 0.01% |
865,570
-50,742
| -6% | -$237K |
|
|
BELFB
557
Bel Fuse Inc Class B
BELFB
$3.59B
| $3.7M | 0.01% |
194,211
-16,505
| -8% | -$364K |
|
|
CIT
558
DELISTED
CIT Group Inc.
CIT
| $3.65M | 0.01% |
80,802
-6,318
| -7% | -$287K |
|
|
FNBC
559
DELISTED
First NBC Bank Holding Company
FNBC
| $3.64M | 0.01% |
110,416
-9,285
| -8% | -$305K |
|
560
New Oriental
EDU
$9.36B
| $3.62M | 0.01% |
163,217
-12,799
| -7% | -$257K |
|
561
Gerdau
GGB
$9.01B
| $3.52M | 0.01% |
1,386,000
+125,235
| +10% | +$348K |
|
562
Independent Bank Corp
IBCP
$818M
| $3.52M | 0.01% |
274,190
+151,320
| +123% | +$1.92M |
|
563
Halliburton
HAL
$30.1B
| $3.5M | 0.01% |
79,814
-36,377
| -31% | -$1.52M |
|
564
Koppers
KOP
$881M
| $3.49M | 0.01% |
177,456
-44,445
| -20% | -$893K |
|
565
Western Union
WU
$2.26B
| $3.49M | 0.01% |
167,660
-12,970
| -7% | -$241K |
|
566
Federated Hermes
FHI
$4.81B
| $3.44M | 0.01% |
101,488
-1,637,994
| -94% | -$54.4M |
|
|
UTEK
567
DELISTED
Ultratech Inc.
UTEK
| $3.39M | 0.01% |
195,610
+15,230
| +8% | +$267K |
|
568
Commercial Metals
CMC
$7.48B
| $3.35M | 0.01% |
206,802
-16,149
| -7% | -$236K |
|
|
FRC
569
DELISTED
First Republic Bank
FRC
| $3.32M | ﹤0.01% |
58,088
+3,369
| +6% | +$183K |
|
570
James River Group Holdings
JRVR
$191M
| $3.25M | ﹤0.01% |
138,320
-11,680
| -8% | -$261K |
|
571
Fastenal
FAST
$57.1B
| $3.21M | ﹤0.01% |
310,400
| – | – |
|
572
Old Second Bancorp
OSBC
$1.28B
| $3.21M | ﹤0.01% |
561,160
+109,135
| +24% | +$595K |
|
573
Goodyear
GT
$1.83B
| $3.17M | ﹤0.01% |
+117,100
| New | +$3.06M |
|
|
QADA
574
DELISTED
QAD Inc.
QADA
| $3.15M | ﹤0.01% |
+130,303
| New | +$2.78M |
|
|
PRGX
575
DELISTED
PRGX Global, Inc.
PRGX
| $3.06M | ﹤0.01% |
760,929
-584,632
| -43% | -$2.87M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.